ライフサイエンスコーパス: dry skin

1 e than 50% of elderly patients have xerosis (dry skin).

2 ssociated with PN, bleeding or scabbing, and dry skin.

3 ly promotes spontaneous itch in experimental dry skin.

4 rected toward Merkel cells in the setting of dry skin.

5 th cyclosporine-treated patients, except for dry skin.

6 cebo-controlled trial enrolling females with dry skin, 2% IDL lotion applied over 2 weeks significant

7 erse events were hypertriglyceridemia (84%), dry skin (34%), asthenia (30%), and headache (27%).

8 etuximab included an acne-like rash (88.6%), dry skin (34.3%), asthenia and skin disorders (31.4%), m

9 proving the management of many patients with dry skin and atopy.

10 verse event (AE), with cutaneous AEs such as dry skin and rash being the most common.

11 Eczema, dry skin, and high TEWL at 3 months increased the risk o

12 Eczema, dry skin, and high TEWL at 3 months predicted allergic s

13 We aimed to determine whether eczema, dry skin, and high transepidermal water loss (TEWL) at 3

14 se events included diarrhea, rash, alopecia, dry skin, and nausea.

15 tes of gastrointestinal disorders, jaundice, dry skin, and photosensitivity were increased at 240 mg

16 n-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting.

17 ght gain, constipation, change in voice, and dry skin, but clinical presentation can differ with age

18 in hepatic transaminases and triglycerides, dry skin, cheilitis, and nausea/vomiting.

19 Finally, chronic itch in a dry skin condition was substantially reduced in Tlr3(-/-

20 AD) is a chronic, pruritic and inflammatory, dry skin condition with many known comorbidities.

21 measurements of volunteers with healthy and dry skin conditions on various parts of the body such as

22 of mice with allergic contact dermatitis- or dry skin-elicited itch; however, spinal ERK activation w

23 d for the dramatic skin changes triggered by dry-skin-evoked itch and scratching.

24 Dry skin, fatigue, itching, and bone/joint pain each wer

25 the skin treated with lipase at 0.30 units/g dry skin for 3h had the highest lipid removal (84.57%) w

26 of emollient and steroid use in infants with dry skin for the prevention of allergy.

27 iver at various levels (0.15 and 0.30units/g dry skin) for 1-3h at 30 degrees C, the skin treated wit

28 , dermatitis acneiform in 69 (78%) patients, dry skin in 39 (44%) patients, and stomatitis in 36 (40%

29 topenia (in 37% of patients), rash (in 34%), dry skin (in 32%), and abdominal pain (in 22%).

30 rogression of some diseases characterized by dry skin, including atopic dermatitis.

31 Xerosis, commonly referred to as dry skin, is a common dermatological condition affecting

32 also displays pronounced deficit in chronic dry skin itch, a type of chemical itch in mice.

33 re associated with skin barrier dysfunction (dry skin, less acidic skin, and fissured skin), and atop

34 In a dry skin model of itch, we show that GRPR blockade or PI

35 The most frequent symptoms were dry skin (n = 20 [65%]), tight skin (n = 19 [61%]), itch

36 rway and Sweden were assessed for eczema and dry skin on the cheeks and/or extensors; impaired skin b

37 ic itch and dermatitis, but not in models of dry skin or compound 48/80- or Alternaria-induced itch.

38 orticosteroid creams, and parental report of dry skin or eczema.

39 ctivity, stereotypy, diarrhea, insomnia, and dry skin or pruritus.

40 th and oedema), dermatological (pruritus and dry skin), painful (muscle cramps, chest pain and abdomi

41 IV), a common skin disorder characterised by dry skin, palmar hyperlinearity and keratosis pilaris.

42 d extraction of phenolics and oil from onion dry skin powder (OSP) which was evaluated by TLC, FT/IR

43 count (18 [46%]), hypertension (six [15%]), dry skin, pruritus, or rash (five [13%]), and anaemia (f

44 epatotoxicity (two [5%]), sepsis (two [5%]), dry skin, pruritus, or rash (one [3%]), nausea (one [3%]

45 In mice with experimental dry skin, there was a time-dependent increase in spontan

46 ith 55.6% sensitivity and 68.1% specificity; dry skin with 65.3% sensitivity and 57.3% specificity; a